© 1993 Oxford University Press
research-article |
Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid)
Department of Pathology, University of Maryland School of Medicine 10 S. Pine Street, Baltimore, MD 21201, USA
1To whom correspondence should be addressed
Inositol hexaphosphate (InsP6 or phytic acid) has been shown to have antineoplastic action in in vivo models of colon carcinogenesis. We therefore investigated its effect on proliferation and differentiation of the human colon cancer cell line HT-29 in vitro. Proliferation was evaluated by neutral red incorporation assay, and differentiation was assessed by expression of the markers, cytokeratin, carcinoembryonic antigen (CEA) and ß-D-galactose-[1->3]-N-acetyl-galactosamine (Gal-GalNAc). InsP6 in the culture media (0.66–10 mM) inhibited cell proliferation in a dose-dependent manner (P < 0.001), while inositol or inositol hexasulfate used as controls or media without InsP6 did not show any suppressive effect. The expression of the tumor marker, Gal-GalNac, was augmented (100.7% increase) by low dose (0.66 mM) of InsP6 but was subsequently suppressed with higher concentrations of InsP6. The expression of cytokeratin and CEA were both augmented by either InsP6 or inositol at all concentrations tested, although the degree of augmentation was milder with inositol than with InsP6. The combination of InsP6 and inositol (both 0.66 mm) resulted in augmentation (P < 0.001) of cytokeratin expression, while that of CEA remained unchanged. The inhibitory effect of InsP6 on cell proliferation was not altered by combination with additional inositol at any concentrations tested. Our results show that InsP6 inhibits cell proliferation and concomitantly increases differentiation and is therefore a candidate chemopreventive and chemotherapeutic agent for human large intestinal cancer.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Liao, D. N. Seril, A. L. Yang, G. G. Lu, and G.-Y. Yang Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compounds Carcinogenesis, February 1, 2007; 28(2): 446 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Vucenik, A. Passaniti, M. I. Vitolo, K. Tantivejkul, P. Eggleton, and A. M. Shamsuddin Anti-angiogenic activity of inositol hexaphosphate (IP6) Carcinogenesis, November 1, 2004; 25(11): 2115 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Vucenik and A. M. Shamsuddin Cancer Inhibition by Inositol Hexaphosphate (IP6) and Inositol: From Laboratory to Clinic J. Nutr., November 1, 2003; 133(11): 3778S - 3784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ferry, M. Matsuda, H. Yoshida, and M. Hirata Inositol hexakisphosphate blocks tumor cell growth by activating apoptotic machinery as well as by inhibiting the Akt/NF{kappa}B-mediated cell survival pathway Carcinogenesis, December 1, 2002; 23(12): 2031 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P Latham, E K Lund, J C Brown, and I T Johnson Effects of cellular redox balance on induction of apoptosis by eicosapentaenoic acid in HT29 colorectal adenocarcinoma cells and rat colon in vivo Gut, July 1, 2001; 49(1): 97 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zi, R. P. Singh, and R. Agarwal Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells Carcinogenesis, December 1, 2000; 21(12): 2225 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jenab and L. U. Thompson Phytic acid in wheat bran affects colon morphology, cell differentiation and apoptosis Carcinogenesis, August 1, 2000; 21(8): 1547 - 1552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A A M van der Wurff, J ten Kate, P T J Marx, E P M van der Linden, C C L Beek, F-J Bovelander, J Dekker, W N M Dinjens, M F von Meyenfeldt, J-W Arends, et al. Expression of a marker for colonic crypt base cells is correlated with poor prognosis in human colorectal cancer Gut, January 1, 1998; 42(1): 63 - 70. [Abstract] [Full Text] [PDF]
|
|